Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      Dr Reddys faces price fixing allegations In US for 4 drugs

      Dr Reddys faces price fixing allegations In US for 4 drugs

      Meghna A Singhania5 Feb 2019 4:06 PM IST
      DRL informed the US stock markets regulator that it has been named with respect to four drugs namely, Divalproex ER, Meprobamate, Pravastatin and...
      New Pharma Policy approved in Haryana, to generate 25000 new jobs

      New Pharma Policy approved in Haryana, to generate 25000 new jobs

      Meghna A Singhania5 Feb 2019 10:53 AM IST
      Haryana: Aiming to attract investment in the pharmaceutical sector to the tune of Rs 2,000 crore and to generate 25,000 new jobs, the Haryana Cabinet...
      Goa DHS join hands with Sanofi India for diabetes awareness

      Goa DHS join hands with Sanofi India for diabetes awareness

      Meghna A Singhania4 Feb 2019 4:13 PM IST
      Directorate of Health Services (Government of Goa) and Sanofi India joined hands to reduce diabetes burden on the State’s health exchequer. The two...
      NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent

      NPPA to decide on Merrills Request for price cap exemption for its biodegradable stent

      Meghna A Singhania3 Feb 2019 11:16 AM IST
      New Delhi: A Year after Abbott's launch of biodegradable stents which was later withdrawn globally, Meril Life Sciences has moved the National...
      SUGAM registration Mandatory: CDSCO directs State drugs controllers to enforce rule

      SUGAM registration Mandatory: CDSCO directs State drugs controllers to enforce rule

      Meghna A Singhania31 Jan 2019 12:46 PM IST
      New Delhi: Through a recent notice, Central Drugs Standard Control Organization informed all drug controllers about online SUGAM registration...
      Meril launches Myval- Indigenously developed TAVR therapy in India

      Meril launches Myval- Indigenously developed TAVR therapy in India

      Meghna A Singhania11 Dec 2018 8:23 PM IST
      New Delhi: In a first, Meril Life Sciences has introduced the first ever indigenously designed and manufactured Transcatheter Aortic Heart Valve...
      Zydus Hospital acquires Columbia Asia Hospital in Ahmadabad

      Zydus Hospital acquires Columbia Asia Hospital in Ahmadabad

      Meghna A Singhania31 Oct 2018 5:26 PM IST
      New Delhi: Zydus Hospitals, a subsidiary of pharma giant Zydus Group, has acquired the Ahmedabad unit of Columbia Asia Hospital Pvt Ltd.The...
      GST Trauma: Chemist Drop medicine storage, Temporary Shortage Likely

      GST Trauma: Chemist Drop medicine storage, Temporary Shortage Likely

      Meghna A Singhania26 Jun 2017 12:04 PM IST
      New Delhi: Uncertain about the impact of GST on their business, chemists across the country, seem to be turning down fresh inventories ahead of its...
      Cipla-Roche Patent Row : Supreme Court allows Cipla to withdraw appeal

      Cipla-Roche Patent Row : Supreme Court allows Cipla to withdraw appeal

      Meghna A Singhania16 Jun 2017 9:35 PM IST
      NEW DELHI: The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over...
      CT scanner at KGS Scans, Madurai Siemens Healthineers installs first SOMATOM go

      CT scanner at KGS Scans, Madurai Siemens Healthineers installs first SOMATOM go

      Meghna A Singhania29 April 2017 3:28 PM IST
      KGS Advanced MRI and CT Scans a Madurai based diagnostic hub installed Siemens Healthineer’s state-of-the-art SOMATOM go. Now- 32 slice CT scanner...
      Sepalika a Healthcare content startup raises $750,000 from Accel

      Sepalika a Healthcare content startup raises $750,000 from Accel

      Meghna A Singhania29 April 2017 3:13 PM IST
      Sepalika, a healthcare content platform has raised $750,000 (Rs 4.8 crore) in seed funding led by venture capital firm Accel Partners. It offers...
      MD Exclusive Interview: Dr V Mohan, Chairman Dr Mohans Diabetes Specialities Centre

      MD Exclusive Interview: Dr V Mohan, Chairman Dr Mohans Diabetes Specialities Centre

      Meghna A Singhania29 April 2017 12:43 PM IST
      Dr. V. Mohan is the Chairman and Chief of Diabetology at Dr. Mohan’s Diabetes Specialities Centre at Chennai in South India which is a WHO...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok